Ribosomal Protein L36aL Inhibitors are chemicals that affect the activity of Ribosomal Protein L36aL by influencing pathways related to ribosome function and protein synthesis. These inhibitors target various molecular mechanisms within these pathways, thereby affecting the functional role of Ribosomal Protein L36aL. The primary mode of indirect inhibition involves targeting protein synthesis. Chemicals like Cycloheximide, Puromycin dihydrochloride, Anisomycin, and Diphtheria Toxin, CRM Mutant disrupt different stages of protein synthesis in eukaryotic cells. Cycloheximide inhibits eukaryotic protein synthesis by interfering with translocation, Puromycin dihydrochloride causes premature chain termination, Anisomycin inhibits peptide elongation, and Diphtheria Toxin, CRM Mutant inhibits elongation factor 2 (EF-2). These actions can indirectly influence the function of ribosomal proteins like Ribosomal Protein L36aL. Antibiotics such as Chloramphenicol, Tetracycline, Erythromycin, Streptomycin, and Azithromycin target bacterial protein synthesis. While their primary action is on bacteria, studying their mechanisms can provide insights into eukaryotic ribosomal function.
Rapamycin, an mTOR inhibitor, affects ribosome biogenesis and protein synthesis in eukaryotic cells. By modulating these processes, Rapamycin can have an indirect impact on the activity of ribosomal proteins including Ribosomal Protein L36aL. Mycophenolic Acid inhibits inosine monophosphate dehydrogenase, which is crucial in the purine synthesis pathway. This inhibition can indirectly affect protein synthesis, thereby impacting Ribosomal Protein L36aL. Ricin inactivates ribosomes by depurinating a specific adenine residue on rRNA. Its mechanism of action, although lethal, provides insights into how ribosomal function can be disrupted, affecting Ribosomal Protein L36aL. While these chemicals do not directly target Ribosomal Protein L36aL, their influence on protein synthesis and ribosome function can indirectly modulate the activity of ribosomal proteins like Ribosomal Protein L36aL. Understanding these indirect interactions is crucial for exploring the broader regulatory networks of protein synthesis and the implications in conditions where Ribosomal Protein L36aL's function is significant.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inhibits eukaryotic protein synthesis, potentially impacting RPL36AL function in ribosome. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor, affects ribosome biogenesis and protein synthesis, potentially impacting Ribosomal Protein L36aL. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $40.00 $210.00 $816.00 $65.00 | 394 | |
Causes premature chain termination during protein synthesis, indirectly affecting Ribosomal Protein L36aL. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Inhibits peptide elongation, potentially impacting Ribosomal Protein L36aL's role in protein synthesis. | ||||||
Chloramphenicol | 56-75-7 | sc-3594 | 25 g | $53.00 | 10 | |
Inhibits bacterial protein synthesis, may indirectly influence Ribosomal Protein L36aL in eukaryotic cells. | ||||||
Tetracycline | 60-54-8 | sc-205858 sc-205858A sc-205858B sc-205858C sc-205858D | 10 g 25 g 100 g 500 g 1 kg | $62.00 $92.00 $265.00 $409.00 $622.00 | 6 | |
Inhibits protein synthesis in bacteria, could have indirect effects on eukaryotic Ribosomal Protein L36aL. | ||||||
Erythromycin | 114-07-8 | sc-204742 sc-204742A sc-204742B sc-204742C | 5 g 25 g 100 g 1 kg | $56.00 $240.00 $815.00 $1305.00 | 4 | |
Binds to bacterial ribosomes, indirectly affecting ribosomal protein function like Ribosomal Protein L36aL. | ||||||
Diphtheria Toxin, CRM Mutant | 92092-36-9 | sc-203924 | 0.25 mg | $639.00 | 1 | |
Inhibits eukaryotic protein synthesis by ADP-ribosylating EF-2, indirectly affecting Ribosomal Protein L36aL. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $68.00 $261.00 | 8 | |
Inhibits inosine monophosphate dehydrogenase, potentially impacting protein synthesis and Ribosomal Protein L36aL. | ||||||
Azithromycin | 83905-01-5 | sc-254949 sc-254949A sc-254949B sc-254949C sc-254949D | 25 mg 50 mg 500 mg 1 g 5 g | $51.00 $101.00 $255.00 $357.00 $714.00 | 17 | |
A macrolide antibiotic, inhibits bacterial protein synthesis, may indirectly influence eukaryotic Ribosomal Protein L36aL. |